Feeding Tolerance and Gut Maturation of Infants Consuming a Formula Rich in Glycoprotein

NACompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

July 9, 2021

Primary Completion Date

December 28, 2022

Study Completion Date

December 28, 2022

Conditions
DigestionGut Microbiota
Interventions
DIETARY_SUPPLEMENT

Commercially Available Starter Infant Formula

Study formula is provided in powder form and will be administered orally, ad libitum, via an infant feeding bottle and the volume of formula offered to the infant will be guided by the recommended feeding table for the age group or by physician recommendation. The amount consumed by the infant will vary by each infant's weight and appetite.

Trial Locations (1)

Unknown

Shanghai Public Health Clinical Center, Shanghai

Sponsors

Collaborators (2)

All Listed Sponsors
collaborator

Medrio, Inc

UNKNOWN

collaborator

SAS Institute

INDUSTRY

collaborator

Veeva Systems

INDUSTRY

lead

Société des Produits Nestlé (SPN)

INDUSTRY

NCT04880083 - Feeding Tolerance and Gut Maturation of Infants Consuming a Formula Rich in Glycoprotein | Biotech Hunter | Biotech Hunter